Dlaczego pacjenci wybierają Izrael na chemioterapię raka wątroby?
Skorzystaj z zaawansowanych rozwiązań chemioterapii raka wątroby w zaufanych klinikach .
| Izrael | Turcja | Austria | |
| Chemioterapia przy raku wątroby | - | od $1,800 | - |
Day 1
Day 2
Day 3
Day 4- Day 28
Weeks 5-8
Week 9 onwards
Please note that each patient"s experience with chemotherapy can vary. Always consult your healthcare team for the most personalized advice.
Dr Pelles Sharon specjalizuje się w zaawansowanych metodach leczenia raka wątroby, w tym w terapii SIRT i chemoembolizacji, w Centrum Medycznym Sourasky.
Prof. Merimsky kieruje Oddziałem Onkologii Tkanek Miękkich i Kości w Centrum Medycznym Sourasky i specjalizuje się w zaawansowanych protokołach chemioterapii.
Dyrektor oddziału hospitalizacji onkologicznej w Centrum Medycznym Tel Awiw – dr Stepfansky kieruje dedykowanym zespołem onkologicznym z bogatym doświadczeniem w badaniach klinicznych.
Prof. Ben Boursi is a physician in the Gastrointestinal Cancer Department at Sheba Medical Center. He specializes in internal medicine, medical oncology, and cancer epidemiology. He is board certified in internal medicine and medical oncology. He earned a B.Med.Sc (summa cum laude) and an MD (magna cum laude) from Tel Aviv University.
He completed clinical and research fellowships in GI oncology and cancer epidemiology at the University of Pennsylvania. He also completed electives at MD Anderson and Mayo Clinic. He founded the ECOG-ACRIN Microbiome Working Group. His microbiome-oncology research has been published in leading journals, including Science, and highlighted by ASCO.
He developed predictive models for early diagnosis of colorectal and pancreatic cancers. These models are now in clinical evaluation. He holds an academic appointment at Tel Aviv University. He is also an Associate Scholar at the University of Pennsylvania.
Involves the use of powerful drugs to target and destroy cancer cells in the liver, aiming to shrink tumors and prevent metastasis.